We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Abbott's HUMIRA® (adalimumab) Receives U.S. FDA Approval

News   Oct 04, 2012

 
Abbott's HUMIRA® (adalimumab) Receives U.S. FDA Approval
 
 
 

RELATED ARTICLES

Is it Flu or Just a Cold?

News

Most people struggle to distinguish between influenza, "real" flu, and the common cold and this often leads to irritation and the perpetuation of myths.

READ MORE

Resistant Melanoma Sensitized to Cytotoxic T Cells with BRAF-targeting

News

BRAF-targeted therapies render resistant melanoma more sensitive to the attack of killer T cells. The findings pave the way in developing therapy for patients that have become resistant to BRAF inhibitors.

READ MORE

Smoking Limits Body’s Ability to Fight Skin Cancer

News

Melanoma patients with a history of smoking cigarettes are 40 per cent less likely to survive their skin cancer than people who have never smoked, according to a new report funded by Cancer Research UK.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE